Loading clinical trials...
Loading clinical trials...
A Phase IV, Multi-center, Open-label, Single-arm 24-hour Ambulatory Blood Pressure Monitoring (ABPM) Study of 16 Weeks Treatment With Androderm® in Hypogonadal Men
Conditions
Interventions
Androderm®
Locations
41
United States
Central Research Associates, Inc.
Birmingham, Alabama, United States
Coastal Clinical Research, LLC, An AMR Co.
Mobile, Alabama, United States
Urological Associates of South Arizona, PC
Tucson, Arizona, United States
Hope Clinical Research
Canoga Park, California, United States
Marvel Clinical Research
Huntington Beach, California, United States
San Diego Clinical Trials
La Mesa, California, United States
Start Date
May 19, 2020
Primary Completion Date
June 24, 2021
Completion Date
June 24, 2021
Last Updated
July 12, 2022
NCT06019182
NCT06689085
NCT06841328
NCT03851627
NCT06094036
NCT06691815
Lead Sponsor
Allergan
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions